SanBio Company Ownership
SNBIF Stock | USD 3.85 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
SanBio |
SanBio OTC Stock Ownership Analysis
About 36.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.59. SanBio Limited had not issued any dividends in recent years. SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company was founded in 2001 and is headquartered in Tokyo, Japan. Sanbio is traded on OTC Exchange in the United States.The quote for SanBio Company Limited is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about SanBio Company Limited contact the company at 81 3 6264 3481 or learn more at https://www.sanbio.jp.Currently Active Assets on Macroaxis
Other Information on Investing in SanBio OTC Stock
SanBio Company financial ratios help investors to determine whether SanBio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SanBio with respect to the benefits of owning SanBio Company security.